Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function
- DOI
- 10.1172/jci157248
- Published
- 2022-10-03
- Container
- Journal of Clinical Investigation
- Publisher
- American Society for Clinical Investigation
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1172/jci157248,
title = {Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function},
author = {Junfeng Wang and Quanyi Wang and Yinan Guan and Yulu Sun and Xiaozhi Wang and Kaylie Lively and Yuzhen Wang and Ming Luo and Julian A. Kim and E. Angela Murphy and Yongzhong Yao and Guoshuai Cai and Daping Fan},
year = {2022},
journal = {Journal of Clinical Investigation},
doi = {10.1172/jci157248},
url = {https://doi.org/10.1172/jci157248}
}RIS
TY - JOUR TI - Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function AU - Junfeng Wang AU - Quanyi Wang AU - Yinan Guan AU - Yulu Sun AU - Xiaozhi Wang AU - Kaylie Lively AU - Yuzhen Wang AU - Ming Luo AU - Julian A. Kim AU - E. Angela Murphy AU - Yongzhong Yao AU - Guoshuai Cai AU - Daping Fan PY - 2022 JO - Journal of Clinical Investigation DO - 10.1172/jci157248 UR - https://doi.org/10.1172/jci157248 ER -
APA
Wang, J., Wang, Q., Guan, Y., Sun, Y., Wang, X., Lively, K., Wang, Y., Luo, M., Kim, J. A., Murphy, E. A., Yao, Y., Cai, G., & Fan, D. (2022). Breast cancer cell–derived microRNA-155 suppresses tumor progression via enhancing immune cell recruitment and antitumor function. Journal of Clinical Investigation. https://doi.org/10.1172/jci157248
Source records
- crossref · retrieved 2026-09-26T07:17:48.683Z